Safely Prescribing Nirmatrelvir and Ritonavir-Avoiding Drug-Drug Interactions.

Culas, Roshni; Nath, Sridesh; Nath, Sarath

Culas, Roshni; Nath, Sridesh; Nath, Sarath.

Afiliação

Culas R; Division of Infectious Disease, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Nath S; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Nath S; Division of Infectious Diseases, Department of Medicine, Stony Brook University Hospital, Stony Brook, New York.

JAMA Intern Med ; 183(4): 362-363, 2023 04 01.

Article em En | MEDLINE | ID: mdl-36807493

This Teachable Moment discusses drug-drug interactions with nirmatrelvir and ritonavir (Paxlovid) treatment for COVID-19 and considerations when prescribing.

Assuntos

Lactamas; Ritonavir; Humanos; Ritonavir/uso terapêutico; Nitrilas; Antivirais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ritonavir / Lactamas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ritonavir / Lactamas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article